Induced TNF production in vitro as a test for familial Mediterranean fever

QJM: An International Journal of Medicine

Volumn 89, Issue 3, 1996, Pages 205-210

  Schattner, A ^a,d   Gurevitz, A ^a   Zemer, D ^b   Hahn, T ^a,c  

^a KAPLAN HOSPITAL   (Israel)

^b HELLER INSTITUTE OF MEDICAL RESEARCH   (Israel)

^c HEBREW UNIVERSITY   (Israel)

^d HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

LIPOPOLYSACCHARIDE; PHYTOHEMAGGLUTININ; TUMOR NECROSIS FACTOR;

ADULT; ARTICLE; BLOOD CELL; BLOOD LEVEL; CELL STIMULATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC VALUE; FAMILIAL MEDITERRANEAN FEVER; FEMALE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

EID: 0029867229     PISSN: 00335622     EISSN: None     Source Type: Journal    
DOI: 10.1093/qjmed/89.3.205     Document Type: Article

References (23)

1. Cook GC. Periodic disease, recurrent polyserositis, familial Mediterranean fever, or simply 'FMF'. Q J Med 1986; 60:819-23.
2. Pras E, Aksentijevich I, Gruberg L, Balow JE Jr, Prosen L, Dean M, Steinberg AD, Pras M, Kastner DL. Mappling of a gene causing familial Mediterranean fever to the short arm of chromosome 16. N Engl J Med 1992; 326:1509-13.
3. Eliakim M, Levy M, Ehrenfeld M. Recurrent polyserositis. Elsevier-Holland/Biomedical Press, Amsterdam, 1981.
4. Barakat MH, Karnik AM, Majeed HWA, el-Sobki NI, Fenech FF. Familial Mediterranean fever (recurrent hereditary polyserositis) in Arabs - a study of 175 patients and review of the literature. Q J Med 1986; 60:837-47.
5. Zemer D, Pras M, Sohar E, Modan M, Cabili S, Gafni J. Colchicine in the prevention and treatment of the amyloidosis of familial Mediterranean fever. N Engl J Med 1986; 314:1001-5.
6. Schattner A, Hahn T. A proposed mechanism of the inflammatory attacks in familial Mediterranean fever. Arch Intern Med 1992; 152:421.
7. Schattner A, Lachmi M, Livneh A, Pras M, Hahn T. Tumor necrosis fector in familial Mediterranean fever. Am J Med 1991; 90:434-8.
8. Sohar E, Gafni J, Pras M, Heller H. Familial Mediterranean fever: a survey of 470 cases and review of the literature. Am J Med 1967; 43:227-53.
9. Desch CE, Kovach NL, Present W, Broyles C, Harlan JM. Production of human tumor necrosis factor from whole blood ex vivo. Lymphokine Res 1989; 8:141-6.
10. Schattner A. Tumor necrosis factor in familial Mediterranean fever. Am J Med 1992; 92:580.
11. Hahn T, Schattner A, Handzel ZT, Levin S, Bentwich Z. Possible role of natural cytotoxic activity in the pathogenesis of AIDS. Clin Immunol Immunopathol 1989; 50:53-61.
12. Schattner A, Steinbock M, Tepper R, Schoenfeld A, Vaisman N, Hahn T. Tumor necrosis factor production and cell-mediated immunity in anorexia nervosa. Clin Exp Immunol 1990; 79:62-6.
13. Ilfeld D, Weil S, Kuperman O. Immunoregulatory abnormalities in familial Mediterranean fever. Clin Immunol Immunopathol 1981; 18:261-7.
14. Barakat MH, El-Khawad AO, Gumaa KA, El-Sobki NI, Fenech FF. Metaraminol provocative test: a specific diagnostic test for familial Mediterranean fever. Lancet 1984; 1:656-7.
15. Buades J, Bassa A, Altes J, Vicens JM, Gabrer B. The metaraminol test and adverse cardiac effects. Am J Med 1989; 111:259-60.
16. Mazner V, Brzezinski A. C5a-inhibitor deficiency in peritoneal fluids from patients with familial Mediterranean fever. N Engl J Med 1984; 311:287-90.
17. Aisen PS, Haines KA, Given W, Abramson SB, Pras M, Serhan C, Hamberg M, Samuelsson B, Weissmann G. Circulating hydroxy fatty acids in familial Mediterranean fever. Proc Natl Acad Sci USA 1985; 82:1232-6.
18. Matzner Y, Partridge REH, Levy M, Babior BM. Diminished activity of a chemotactic inhibitor inn synovial fluids from patients with familial Mediterranean fever. Blood 1984; 63:629-33.
19. Rothstein JL, Lint TF, Schreiber H. Tumor necrosis factor/ cachectin. Induction of hemorrhagic necrosis in normal tissue requires the fifth component of complement (C5). J Exp Med 1988; 168:2007-21.
20. Cavaillon JM, Fitting C, Haeffner-Cavaillon N. Recombinant C5a enhances interleukin 1 and tumor necrosis factor release by lipopolysaccharide-stimulated monocytes and macrophages. Eur J Immunol 1990; 20:253-7.
21. Bajaj MS, Kew RR, Webster RO, Hyers TM. Priming of human neutrophil functions by tumor necrosis factor: enhancement of superoxide anion generation, degranulation, and chemotaxis to chemoattractants C5a and F-Met-Leu-Phe. Inflammation 1992; 16:241-50.
22. Chuluyan HE, Issekutz AC: VLA-4 integrin can mediate CD11/18-independent transendothelial migration of human monocytes. J Clin Invest 1993; 92:2760-77.
23. Palmantier R, Surette ME, Sanchez A, Braquet P, Borgeat P. Priming for the synthesis of 5-lipoxygenase products in human blood and tumor necrosis factor-alpha. Lab Invest 1994; 70:696-704.